These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20001979)

  • 1. [Provision of complex cardioprotection with the help of carvedilol in 1-2 degree arterial hypertension combined with metabolic syndrome].
    Oleĭnikov VE; Matrosova IB; Eliseeva IV; Tomashevskaia IuA; Gusakovskaia LI
    Kardiologiia; 2009; 49(11):27-32. PubMed ID: 20001979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative efficacy of carvedilol and capoten in the treatment of an uncomplicated hypertensive crisis].
    Tereshchenko SN; Dzhaiani NA; Morozova MN
    Ter Arkh; 2006; 78(8):26-30. PubMed ID: 17078213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart rate variability dynamics during treatment of arterial hypertension].
    Riabykina GV; Chazova IE; Mychka VB; Shutova LI; Shishova TV; Liutikova LN; Kozhemiakina ESh; Shchedrina EV; Sobolev AV
    Kardiologiia; 2008; 48(7):18-24. PubMed ID: 18789021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First results of open randomized clinical study of Acridilol in combination therapy of patients with arterial hypertension and obesity or type 2 diabetes (Mellitus-Open Multicenter Clinical Study ACCORD)].
    Shal'nova SA; Martsevich SIu; Deev AD; Lukina IuV; Oganov RG
    Kardiologiia; 2008; 48(8):28-33. PubMed ID: 18789007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.
    Galioto A; Semplicini A; Zanus G; Fasolato S; Sticca A; Boccagni P; Frigo AC; Cillo U; Gatta A; Angeli P
    Liver Transpl; 2008 Jul; 14(7):1020-8. PubMed ID: 18581464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
    Bruns LA; Chrisant MK; Lamour JM; Shaddy RE; Pahl E; Blume ED; Hallowell S; Addonizio LJ; Canter CE
    J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
    Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive activity and cerebroprotective properties of carvedilol in patients with arterial hypertension associated with type 2 diabetes mellitus].
    Mordovin VF; Belokopytova NV; Fal'kovskaia AIu; Efimova IIu
    Kardiologiia; 2007; 47(10):31-6. PubMed ID: 18260941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
    Galioto A; Angeli P; Guarda S; Burra P; Zanus G; Fasolato S; Fagiuoli S; Sticca A; Semplicini A; Sartori M; Carraro A; Boccagni P; Cillo U; Gatta A
    Transplant Proc; 2005 Mar; 37(2):1245-7. PubMed ID: 15848684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu
    Kardiologiia; 2003; 43(2):69-70. PubMed ID: 12913988
    [No Abstract]   [Full Text] [Related]  

  • 12. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
    Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
    J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F; Ciriello G
    Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
    Kim EJ; Song WH; Lee JU; Shin MS; Lee S; Kim BO; Hong KS; Han SW; Park CG; Seo HS
    Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.